A Systematic Review of Studies Published between 2016 and 2019 on the Effectiveness and Efficacy of Pneumococcal Vaccination on Pneumonia and Invasive Pneumococcal Disease in an Elderly Population

Adult vaccination is high on the agenda in many countries. Two different vaccines are available for the prevention of pneumococcal disease in adults: a 23-valent polysaccharide vaccine (PPV23), and a 13-valent conjugated vaccine (PCV13). The objective of this review is to update the evidence base fo...

Full description

Bibliographic Details
Main Authors: Jacob Dag Berild, Brita Askeland Winje, Didrik Frimann Vestrheim, Hans-Christian Slotved, Palle Valentiner-Branth, Adam Roth, Jann Storsäter
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/9/4/259
_version_ 1797571559491108864
author Jacob Dag Berild
Brita Askeland Winje
Didrik Frimann Vestrheim
Hans-Christian Slotved
Palle Valentiner-Branth
Adam Roth
Jann Storsäter
author_facet Jacob Dag Berild
Brita Askeland Winje
Didrik Frimann Vestrheim
Hans-Christian Slotved
Palle Valentiner-Branth
Adam Roth
Jann Storsäter
author_sort Jacob Dag Berild
collection DOAJ
description Adult vaccination is high on the agenda in many countries. Two different vaccines are available for the prevention of pneumococcal disease in adults: a 23-valent polysaccharide vaccine (PPV23), and a 13-valent conjugated vaccine (PCV13). The objective of this review is to update the evidence base for vaccine efficacy and effectiveness of PPV23 and PCV13 against invasive pneumococcal disease and pneumonia among an unselected elderly population. We systematically searched for clinical trials and observational studies published between January 1 2016 and April 17 2019 in Pubmed, Embase, Cinahl, Web of Science, Epistemonikos and Cochrane databases. Risk of bias was assessed using Cochrane Risk of Bias tool for and the Newcastle–Ottawa Scale. Results were stratified by vaccine type and outcome. We identified nine studies on PCV13 and six on PPV23. No new randomized clinical trials were identified. Due to different outcomes, it was not possible to do a meta-analysis. New high-quality observational studies indicate protective vaccine effectiveness for both vaccines against vaccine type pneumonia. Our estimates for the protective vaccine efficacy and effectiveness (VE) of PPV23 on pneumonia and pneumococcal pneumonia overlap with results from previously published reviews. Some of the results indicate that the effectiveness of the PPV23 is best in younger age groups, and that it decreases over time.
first_indexed 2024-03-10T20:42:15Z
format Article
id doaj.art-a95a8342b96b4882b96e82cb5a4d9094
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-03-10T20:42:15Z
publishDate 2020-04-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-a95a8342b96b4882b96e82cb5a4d90942023-11-19T20:36:43ZengMDPI AGPathogens2076-08172020-04-019425910.3390/pathogens9040259A Systematic Review of Studies Published between 2016 and 2019 on the Effectiveness and Efficacy of Pneumococcal Vaccination on Pneumonia and Invasive Pneumococcal Disease in an Elderly PopulationJacob Dag Berild0Brita Askeland Winje1Didrik Frimann Vestrheim2Hans-Christian Slotved3Palle Valentiner-Branth4Adam Roth5Jann Storsäter6Department of Vaccine Preventable Diseases, Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, 0213 Oslo, NorwayDepartment of Vaccine Preventable Diseases, Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, 0213 Oslo, NorwayDepartment of Vaccine Preventable Diseases, Division of Infection Control and Environmental Health, Norwegian Institute of Public Health, 0213 Oslo, NorwayDepartment of Bacteria, Parasites and Fungi, Statens Serum Institute, 2300 Copenhagen, DenmarkInfectious Disease Epidemiology & Prevention, Statens Serum Institute, 2300 Copenhagen, DenmarkUnit for Vaccination Programmes, Public Health Agency of Sweden, 171 82 Solna, SwedenUnit for Vaccination Programmes, Public Health Agency of Sweden, 171 82 Solna, SwedenAdult vaccination is high on the agenda in many countries. Two different vaccines are available for the prevention of pneumococcal disease in adults: a 23-valent polysaccharide vaccine (PPV23), and a 13-valent conjugated vaccine (PCV13). The objective of this review is to update the evidence base for vaccine efficacy and effectiveness of PPV23 and PCV13 against invasive pneumococcal disease and pneumonia among an unselected elderly population. We systematically searched for clinical trials and observational studies published between January 1 2016 and April 17 2019 in Pubmed, Embase, Cinahl, Web of Science, Epistemonikos and Cochrane databases. Risk of bias was assessed using Cochrane Risk of Bias tool for and the Newcastle–Ottawa Scale. Results were stratified by vaccine type and outcome. We identified nine studies on PCV13 and six on PPV23. No new randomized clinical trials were identified. Due to different outcomes, it was not possible to do a meta-analysis. New high-quality observational studies indicate protective vaccine effectiveness for both vaccines against vaccine type pneumonia. Our estimates for the protective vaccine efficacy and effectiveness (VE) of PPV23 on pneumonia and pneumococcal pneumonia overlap with results from previously published reviews. Some of the results indicate that the effectiveness of the PPV23 is best in younger age groups, and that it decreases over time.https://www.mdpi.com/2076-0817/9/4/259pneumococcal vaccinesreviewinvasive pneumococcal diseasepneumoniaelderly
spellingShingle Jacob Dag Berild
Brita Askeland Winje
Didrik Frimann Vestrheim
Hans-Christian Slotved
Palle Valentiner-Branth
Adam Roth
Jann Storsäter
A Systematic Review of Studies Published between 2016 and 2019 on the Effectiveness and Efficacy of Pneumococcal Vaccination on Pneumonia and Invasive Pneumococcal Disease in an Elderly Population
Pathogens
pneumococcal vaccines
review
invasive pneumococcal disease
pneumonia
elderly
title A Systematic Review of Studies Published between 2016 and 2019 on the Effectiveness and Efficacy of Pneumococcal Vaccination on Pneumonia and Invasive Pneumococcal Disease in an Elderly Population
title_full A Systematic Review of Studies Published between 2016 and 2019 on the Effectiveness and Efficacy of Pneumococcal Vaccination on Pneumonia and Invasive Pneumococcal Disease in an Elderly Population
title_fullStr A Systematic Review of Studies Published between 2016 and 2019 on the Effectiveness and Efficacy of Pneumococcal Vaccination on Pneumonia and Invasive Pneumococcal Disease in an Elderly Population
title_full_unstemmed A Systematic Review of Studies Published between 2016 and 2019 on the Effectiveness and Efficacy of Pneumococcal Vaccination on Pneumonia and Invasive Pneumococcal Disease in an Elderly Population
title_short A Systematic Review of Studies Published between 2016 and 2019 on the Effectiveness and Efficacy of Pneumococcal Vaccination on Pneumonia and Invasive Pneumococcal Disease in an Elderly Population
title_sort systematic review of studies published between 2016 and 2019 on the effectiveness and efficacy of pneumococcal vaccination on pneumonia and invasive pneumococcal disease in an elderly population
topic pneumococcal vaccines
review
invasive pneumococcal disease
pneumonia
elderly
url https://www.mdpi.com/2076-0817/9/4/259
work_keys_str_mv AT jacobdagberild asystematicreviewofstudiespublishedbetween2016and2019ontheeffectivenessandefficacyofpneumococcalvaccinationonpneumoniaandinvasivepneumococcaldiseaseinanelderlypopulation
AT britaaskelandwinje asystematicreviewofstudiespublishedbetween2016and2019ontheeffectivenessandefficacyofpneumococcalvaccinationonpneumoniaandinvasivepneumococcaldiseaseinanelderlypopulation
AT didrikfrimannvestrheim asystematicreviewofstudiespublishedbetween2016and2019ontheeffectivenessandefficacyofpneumococcalvaccinationonpneumoniaandinvasivepneumococcaldiseaseinanelderlypopulation
AT hanschristianslotved asystematicreviewofstudiespublishedbetween2016and2019ontheeffectivenessandefficacyofpneumococcalvaccinationonpneumoniaandinvasivepneumococcaldiseaseinanelderlypopulation
AT pallevalentinerbranth asystematicreviewofstudiespublishedbetween2016and2019ontheeffectivenessandefficacyofpneumococcalvaccinationonpneumoniaandinvasivepneumococcaldiseaseinanelderlypopulation
AT adamroth asystematicreviewofstudiespublishedbetween2016and2019ontheeffectivenessandefficacyofpneumococcalvaccinationonpneumoniaandinvasivepneumococcaldiseaseinanelderlypopulation
AT jannstorsater asystematicreviewofstudiespublishedbetween2016and2019ontheeffectivenessandefficacyofpneumococcalvaccinationonpneumoniaandinvasivepneumococcaldiseaseinanelderlypopulation
AT jacobdagberild systematicreviewofstudiespublishedbetween2016and2019ontheeffectivenessandefficacyofpneumococcalvaccinationonpneumoniaandinvasivepneumococcaldiseaseinanelderlypopulation
AT britaaskelandwinje systematicreviewofstudiespublishedbetween2016and2019ontheeffectivenessandefficacyofpneumococcalvaccinationonpneumoniaandinvasivepneumococcaldiseaseinanelderlypopulation
AT didrikfrimannvestrheim systematicreviewofstudiespublishedbetween2016and2019ontheeffectivenessandefficacyofpneumococcalvaccinationonpneumoniaandinvasivepneumococcaldiseaseinanelderlypopulation
AT hanschristianslotved systematicreviewofstudiespublishedbetween2016and2019ontheeffectivenessandefficacyofpneumococcalvaccinationonpneumoniaandinvasivepneumococcaldiseaseinanelderlypopulation
AT pallevalentinerbranth systematicreviewofstudiespublishedbetween2016and2019ontheeffectivenessandefficacyofpneumococcalvaccinationonpneumoniaandinvasivepneumococcaldiseaseinanelderlypopulation
AT adamroth systematicreviewofstudiespublishedbetween2016and2019ontheeffectivenessandefficacyofpneumococcalvaccinationonpneumoniaandinvasivepneumococcaldiseaseinanelderlypopulation
AT jannstorsater systematicreviewofstudiespublishedbetween2016and2019ontheeffectivenessandefficacyofpneumococcalvaccinationonpneumoniaandinvasivepneumococcaldiseaseinanelderlypopulation